August 22nd, 2024 (Shanghai) — We are glad to announce that Julie Powell, the Corporate Development Director of Pleco Therapeutics, will be presenting at the ACCESS CHINA Partnering Forum – Autumn Virtual Showcase during September 24th to 25th, and 27th, 2024. ACCESS CHINA Biotech Forum is the largest corporate access event between Asia and the Western biopharma industry.
About Pleco Therapeutics
Pleco Therapeutics BV is a private Dutch biopharmaceutical company developing a portfolio of therapies in the field of cancer medicine.
We use a novel approach that aims to increase the sensitivity of cancer cells to chemotherapy. We are transforming care for difficult-to-treat cancers by adopting this innovative approach to overcome drug resistance.
Pleco works with a global network of academic and clinical centers, and contract research organizations to develop and test novel products that increase the effectiveness of chemotherapy, thus changing the balance of outcomes for cancer patients, improving treatment-outcome and extending life. Our experienced team has a fast-to-market development strategy. The company has clinical proof of concept and has been granted the Orphan Drug Designation by the FDA.
About the speaker
Julie has over 10 years of experience in the pharmaceutical industry, with a strong focus on implementing innovative commercial marketing and distribution strategies to drive global market expansion. Over the course of her career, Julie has successfully led the management and launch of pharmaceutical products across a broad range of therapeutic areas, consistently achieving growth and market penetration.
Julie’s expertise spans from strategic product management to leading cross-functional teams in both established markets and emerging sectors. Her deep understanding of market dynamics and patient needs has enabled her to develop tailored solutions that deliver measurable results.
Julie holds a Master’s degree in Business and Marketing Product Management, is ABPI qualified, and joined Pleco Therapeutics in May 2021.
About ACCESS CHINA Partnering Forum
ACCESS CHINA Partnering Forum – Autumn Virtual Showcase is scheduled to be held on September 24th to 25th, and 27th, 2024, via Zoom webinar. This event helps biotechs/pharmas efficiently present their assets in front of 500+ healthcare companies and VCs online. During the event, audience can have access to innovative pharma and healthcare products from worldwide.
Conference Name: ACCESS CHINA Partnering Forum
Date & Time: Sep 24 – 25 (live), and 27 (VoD) 2024, China time
Content: Keynote Speeches, Panel Discussion, Company Presentations, ChemPartner-ACCESS CHINA Dinner Reception
Scale: Expected 500+ participants Online; 100 company roadshows
Participants: Pharma/Biotech senior management and BDs
View more information at https://biotochina.org/
REGISTER
To Register for ACCESS CHINA online, please visit: ACCESS CHINA Biotech Forum
For more information, please contact:
Wendi Xiang
Wxiang@yafocapital.com
BioToChina.org 